Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 β1-adrenoceptors versus Gly389 β1-adrenoceptors in isolated human atrial myocardium

British Journal of Pharmacology

Volumn 138, Issue 2, 2003, Pages 386-392

  Sandilands, A J ^a   O'Shaughnessy, K M ^a   Brown, M J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cyclic AMP; G protein; Genetic polymorphism; Human myocardium

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ARGININE; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA; GLYCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; NORADRENALIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEART ATRIUM APPENDAGE; HEART ATRIUM MUSCLE; HEART VALVE SURGERY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INOTROPISM; MALE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN VARIANT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0037272359     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705030     Document Type: Article

References (25)

1. ANDREN, B., LIND, L., HEDENSTIERNA, G. & LITHELL, A. (1998). LV diastolic function in a population sample of elderly men. Echo., 15, 433-450.
2. 1-adrenergic receptor gene and hypertension. Circulation, 104, 187-190.
3. BOHM, M., FLESCH, M. & SCHNABEL, P. (1997). Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J. Mol. Med., 75, 842-848.
4. 1-adrenergic receptor associated with survival in patients with heart failure. Eur. Heart J., 21, 1853-1858.
5. 1 adrenoceptor polymorphism in humans. Pharmacogenetics, 11, 199-205.
6. HALL, J.A., KAUMANN, A.J. & BROWN, M.J. (1990). Selective β-1AR blockade enhances positive inotropic responses to endogenous catecholamines mediated through β-2 AR's in human atrial myocardium. Circ. Res., 61, 1610-1623.
7. ILERAL, A., KONDAPENEUI, J., HLA, A. & SHIRAM, J. (2001). Influence of age on left atrial appendage function in non-valvular atrial fibrillation. Clin. Cardiology, 24, 39-44.
8. KAUMANN, A.J., HALL, J.A., MURRAY, K.J., WELLS, F.C. & BROWN, M.J. (1989). A comparison of the effects of adrenaline and noradrenaline on human heart and the role of the β-1 and β-2 AR's in the stimulation of AC and contractile force. Eur. Heart J., 10, 29-37.
9. LAHINI, D.K. & NURNBERGER, J.I. (1991). A rapid and non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucl. Acid Res., 19, 5444.
10. LIGGETT, S.B., SHAH, S.D. & CRYER, P.E. (1989). Human tissue adrenergic receptors are not predictive of responses to epinephrine in vivo. Am. J. Physiol., 256, 600-609.
11. MAQBOOL, A., HALL, A.S., BALL, S.G. & BALMFORTH, A.J. (1999). Common polymorphisms of betal-adrenoceptor: identification and rapid screening assay. Lancet, 353, 897.
12. MARTINSSON, A., LINDWALL, K., MELCHER, A. & HJEMDAHL, P. (1989). Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration effect as compared with dose effect, evaluation and influence of autonomic reflexes. Br. J. Clin. Pharm., 28, 83-94.
13. MASON, D.A., MOORE, J.D., GREEN, S.A. & LIGGETT, S.B. (1999). A gain-of-function polymorphism in a G-protein coupling domain of the human betal-adrenergic receptor. J. Biol. Chem., 274, 12670-12674.
14. MONTEITH, S.M., WANG, T. & BROWN, M.J. (1995). Differences in transcription and translation of long and short Gsα, the stimulatory G-protein, in human atrium. Clin. Sci., 89, 487-495.
15. MOLENAAR, P., SARSERO, D., ARCH, J.R., KELLY, J., HENSON, S.M. & KAUMANN, A.J. (1997). Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors. Br. J. Pharmacol., 120, 65-76.
16. MURRAY, K.J., ENGLAND, P.J., LYNHAM, J.A., MILLS, D., SCHMITZ-PEIFFER, C. & REEVES, M.L. (1990). Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues. Biochem. J., 267, 703-708.
17. O'SHAUGHNESSY, K.M., FU, B., DICKERSON, C., THURSTON, D. & BROWN, M.J. (2000). The gain of function variant (R389G) of the β-1 AR does not influence blood pressure or response to β-blockade in hypertensive subjects. Clin. Sci. (Lond.), 99, 233-238.
18. PODLOWSKI, S., WENGEL, K., LUTHER, H., MULLER, J., BRAMLAGE, P., BAUMANN, G., FELIX, S., SPEER, A., HETZER, R., KOPKE, K., HOEHE, M. & WALLUKAT, G. (2000). β-1 adrenoceptor gene variations: a role in IDCM. J. Mol. Med., 78, 87-93.
19. RANADE, K., JORGENSON, E., H-SHEU, W., PEI, D., HSIUNG, C.A., CHIANG, F., CHEN, Y.I., PRATT, R., OLSHEN, R.A., CURB, D., COX. D.R., BOTSTEIN, D. & RISCH, N. (2002). A polymorphism in the β1 adrenergic receptor is associated with resting heart rate. Am. J. Hum. Genet., 70, 935-942.
20. 1-adrenergic receptor affect agonist-promoted trafficking. J. Cardiovascular Pharm., 39, 155-160.
21. SANDILANDS, A.J., O'SHAUGHNESSY, K.M., KAUMANN, A.J. & BROWN, M.J. (2001). Increased inotropic potency of noradrenaline through the R389 β-1 adrenoceptor gene variant compared to G389 variant in isolated human myocardium. J. Hum. Hypertens., 15, 1. (abstr).
22. STADEL, J.M. & LEFKOWITZ, R.J. (1991). Beta-adrenergic receptors: Identification and characterization by radioligand binding studies. In Perkins, J.P. (ed.). The beta-adrenergic receptors. The receptor series. Humana Press: pp. 1-40.
23. WANG, T. & BROWN, M.J. (2002). Influence of betal-adrenoceptor blockade on the gene expression of adenylate cyclase subtypes and beta-adrenoceptor kinase in human atrium. Clin. Sci. (Lond.), 101, 211-217.
24. WHALEY, B.S., YUAN, N. BIRNBAUMER, L., CLARK, R.B. & BARBER, R. (1994). Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. Mol. Pharmacol., 45, 481-489.
25. XIE, H.G., DISKY, V., SOFOWORA, G., KIM, R.B., LANDAU, R., SMILEY, R.M., ZHOU, H.H., WOODS, A.J., HARRIS, P. & STEIN, C.M. (2001). Arg389Gly beta-1 adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter the response in-vivo. Pharmacogenetics, 11, 191-197.